102 related articles for article (PubMed ID: 16803517)
1. Interleukin-6 polymorphisms and the risk of cervical cancer.
Nogueira de Souza NC; Brenna SM; Campos F; Syrjänen KJ; Baracat EC; Silva ID
Int J Gynecol Cancer; 2006; 16(3):1278-82. PubMed ID: 16803517
[TBL] [Abstract][Full Text] [Related]
2. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
3. Stratification analysis and case-control study of relationships between interleukin-6 gene polymorphisms and cervical cancer risk in a Chinese population.
Shi WJ; Liu H; Wu D; Tang ZH; Shen YC; Guo L
Asian Pac J Cancer Prev; 2014; 15(17):7357-62. PubMed ID: 25227842
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the interleukin 6 gene and additional gene-gene interaction contribute to cervical cancer susceptibility in Eastern Chinese women.
Pu X; Gu Z; Wang X
Arch Gynecol Obstet; 2016 Nov; 294(6):1305-1310. PubMed ID: 27535759
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 gene polymorphism and cervical cancer risk.
Tamandani DM; Shekari M; Suri V
Am J Clin Oncol; 2009 Oct; 32(5):524-8. PubMed ID: 19487916
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical Cancer and Ovarian Cancer.
Hashemzehi A; Karimi-Zarchi M; Parsaeian SF; Asadian F; Golestanpour H; Setayesh S; Shaker SA; Zare-Shehneh M; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2867-2871. PubMed ID: 34582655
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
Singh H; Sachan R; Goel H; Mittal B
BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women.
Roh JW; Kim MH; Seo SS; Kim SH; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
Cancer Lett; 2002 Oct; 184(1):57-63. PubMed ID: 12104048
[TBL] [Abstract][Full Text] [Related]
9. Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer.
Singh H; Jain M; Sachan R; Mittal B
Int J Gynecol Cancer; 2009 Oct; 19(7):1190-4. PubMed ID: 19823053
[TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis.
Karakus N; Yigit S; Rustemoglu A; Kalkan G; Bozkurt N
Arch Dermatol Res; 2014 Mar; 306(2):173-80. PubMed ID: 23982631
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
12. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta-511 polymorphism and risk of cervical cancer.
Kang S; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
J Korean Med Sci; 2007 Feb; 22(1):110-3. PubMed ID: 17297261
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
15. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer.
Gangwar R; Mittal B; Mittal RD
Int J Biol Markers; 2009; 24(1):11-6. PubMed ID: 19404917
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
18. Association between six genetic variants of IL-17A and IL-17F and cervical cancer risk: a case-control study.
Lv Q; Zhu D; Zhang J; Yi Y; Yang S; Zhang W
Tumour Biol; 2015 May; 36(5):3979-84. PubMed ID: 25596084
[TBL] [Abstract][Full Text] [Related]
19. Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women.
Al-Tahhan MA; Etewa RL; El Behery MM
Mol Cell Biochem; 2011 Jul; 353(1-2):159-65. PubMed ID: 21424904
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
